Matches in SemOpenAlex for { <https://semopenalex.org/work/W3110475839> ?p ?o ?g. }
- W3110475839 endingPage "129800" @default.
- W3110475839 startingPage "129800" @default.
- W3110475839 abstract "Abstract Background Due to the importance of both prostaglandins (PGs) and leukotrienes (LTs) as pro-inflammatory mediators, and the potential for eicosanoid shunting in the presence of pathway target inhibitors, we have investigated an approach to inhibiting the formation of both PGs and LTs as part of a multi-targeted drug discovery effort. Methods We generated ligand-protein X-ray crystal structures of known inhibitors of microsomal prostaglandin E2 synthase-1 (mPGES-1) and the 5-Lipoxygenase Activating Protein (FLAP), with their respective proteins, to understand the overlapping pharmacophores. We subsequently used molecular modeling and structure-based drug design (SBDD) to identify hybrid structures intended to inhibit both targets. Results This work enabled the preparation of compounds 4 and 5, which showed potent in vitro inhibition of both targets. Significance Our findings enhance the structural understanding of mPGES-1 and FLAP's unique ligand binding pockets and should accelerate the discovery of additional dual inhibitors for these two important integral membrane protein drug targets." @default.
- W3110475839 created "2020-12-07" @default.
- W3110475839 creator A5003698054 @default.
- W3110475839 creator A5008482605 @default.
- W3110475839 creator A5009062063 @default.
- W3110475839 creator A5037362846 @default.
- W3110475839 creator A5040346731 @default.
- W3110475839 creator A5041666989 @default.
- W3110475839 creator A5057230721 @default.
- W3110475839 creator A5062253236 @default.
- W3110475839 creator A5063151497 @default.
- W3110475839 creator A5071194529 @default.
- W3110475839 creator A5073292373 @default.
- W3110475839 creator A5075502305 @default.
- W3110475839 creator A5077722644 @default.
- W3110475839 creator A5077781498 @default.
- W3110475839 creator A5079258645 @default.
- W3110475839 creator A5080605055 @default.
- W3110475839 creator A5082570154 @default.
- W3110475839 creator A5084367460 @default.
- W3110475839 creator A5089744454 @default.
- W3110475839 date "2021-02-01" @default.
- W3110475839 modified "2023-10-16" @default.
- W3110475839 title "Structure-based, multi-targeted drug discovery approach to eicosanoid inhibition: Dual inhibitors of mPGES-1 and 5-lipoxygenase activating protein (FLAP)" @default.
- W3110475839 cites W129031804 @default.
- W3110475839 cites W1629878108 @default.
- W3110475839 cites W1856590789 @default.
- W3110475839 cites W1992564723 @default.
- W3110475839 cites W2001162433 @default.
- W3110475839 cites W2006306072 @default.
- W3110475839 cites W2007187686 @default.
- W3110475839 cites W2009091144 @default.
- W3110475839 cites W2013191257 @default.
- W3110475839 cites W2018716226 @default.
- W3110475839 cites W2024233889 @default.
- W3110475839 cites W2027728403 @default.
- W3110475839 cites W2030324956 @default.
- W3110475839 cites W2033029295 @default.
- W3110475839 cites W2054963607 @default.
- W3110475839 cites W2065812194 @default.
- W3110475839 cites W2080504447 @default.
- W3110475839 cites W2082585817 @default.
- W3110475839 cites W2101449587 @default.
- W3110475839 cites W2108687569 @default.
- W3110475839 cites W2114376947 @default.
- W3110475839 cites W2122093696 @default.
- W3110475839 cites W2125906111 @default.
- W3110475839 cites W2128056712 @default.
- W3110475839 cites W2129935236 @default.
- W3110475839 cites W2153202165 @default.
- W3110475839 cites W2162392926 @default.
- W3110475839 cites W2205687434 @default.
- W3110475839 cites W2224870483 @default.
- W3110475839 cites W2514734288 @default.
- W3110475839 cites W2554398789 @default.
- W3110475839 cites W2591025405 @default.
- W3110475839 cites W2626246102 @default.
- W3110475839 cites W2791101683 @default.
- W3110475839 cites W2792001755 @default.
- W3110475839 cites W2914637605 @default.
- W3110475839 cites W2922021750 @default.
- W3110475839 cites W3006647090 @default.
- W3110475839 cites W3026818880 @default.
- W3110475839 cites W304648589 @default.
- W3110475839 doi "https://doi.org/10.1016/j.bbagen.2020.129800" @default.
- W3110475839 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33246032" @default.
- W3110475839 hasPublicationYear "2021" @default.
- W3110475839 type Work @default.
- W3110475839 sameAs 3110475839 @default.
- W3110475839 citedByCount "9" @default.
- W3110475839 countsByYear W31104758392021 @default.
- W3110475839 countsByYear W31104758392022 @default.
- W3110475839 countsByYear W31104758392023 @default.
- W3110475839 crossrefType "journal-article" @default.
- W3110475839 hasAuthorship W3110475839A5003698054 @default.
- W3110475839 hasAuthorship W3110475839A5008482605 @default.
- W3110475839 hasAuthorship W3110475839A5009062063 @default.
- W3110475839 hasAuthorship W3110475839A5037362846 @default.
- W3110475839 hasAuthorship W3110475839A5040346731 @default.
- W3110475839 hasAuthorship W3110475839A5041666989 @default.
- W3110475839 hasAuthorship W3110475839A5057230721 @default.
- W3110475839 hasAuthorship W3110475839A5062253236 @default.
- W3110475839 hasAuthorship W3110475839A5063151497 @default.
- W3110475839 hasAuthorship W3110475839A5071194529 @default.
- W3110475839 hasAuthorship W3110475839A5073292373 @default.
- W3110475839 hasAuthorship W3110475839A5075502305 @default.
- W3110475839 hasAuthorship W3110475839A5077722644 @default.
- W3110475839 hasAuthorship W3110475839A5077781498 @default.
- W3110475839 hasAuthorship W3110475839A5079258645 @default.
- W3110475839 hasAuthorship W3110475839A5080605055 @default.
- W3110475839 hasAuthorship W3110475839A5082570154 @default.
- W3110475839 hasAuthorship W3110475839A5084367460 @default.
- W3110475839 hasAuthorship W3110475839A5089744454 @default.
- W3110475839 hasBestOaLocation W31104758391 @default.
- W3110475839 hasConcept C124952713 @default.
- W3110475839 hasConcept C142362112 @default.
- W3110475839 hasConcept C181199279 @default.
- W3110475839 hasConcept C185592680 @default.